Robotic Endoscopy Devices Market To Reach $4.46 Billion By 2030

Robotic Endoscopy Devices Market Growth & Trends

The global robotic endoscopy devices market size is expected to reach USD 4.46 billion by 2030, registering a CAGR of 8.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising preference for Minimally Invasive Surgical (MIS) procedures, recent product approvals by the regulatory bodies such as the U.S. Food and Drug Administration (FDA), and prevalence of chronic diseases are the key factors driving the growth.

Robotic endoscopy devices are developed to overcome the limitations of standard diagnostic and therapeutic procedures. The benefits of robotic endoscopy devices in surgical procedures include fast recovery time, reduced post-surgery complications, and minimized scars, thus reduced the duration of hospital stays. Such benefits are anticipated to drive the robotic endoscopy devices market in the forthcoming years.

Factors such as new product developments, approvals, and technological advancements are projected to further fuel the market growth. For instance, in March 2018, Auris Health (Johnson & Johnson) announced the FDA clearance for its Monarch Endoscopy platform. The robotic endoscopy system developed by Medineering GmbH received CE mark approval in the European Union in 2016. Medineering also received the CE approval for its endoscope robot in February 2018.

 Request a free sample copy or view report summary: Robotic Endoscopy Devices Market Report

Robotic Endoscopy Devices Market Report Highlights

• Therapeutic product segment dominated the market and accounted for a share of 96.2% in 2023 owing to the rise in gastrointestinal disorder cases, which necessitate advanced diagnostics and therapeutic innovations, thereby significantly increasing the demand for this segment.

• The laparoscopy applications segment accounted for the largest market revenue share at 47.8% in 2013. This growth is attributed to the improved outcomes of surgeries compared to alternative technologies.

• The outpatient facilities segment dominated the market in 2023. The growth drivers for this segment are technological advancements that have enhanced treatment with cost-effective features.

• North American robotic endoscopy devices market dominated the market with revenue share of 40.54% in 2023.

• The Asia Pacific robotic endoscopy devices market is expected to grow at a CAGR of 10.1% from 2024 to 2030 owing to the rising cases of urological, respiratory, and gastrointestinal diseases, which necessitate diagnosis and thus increase the demand for these products.

Robotic Endoscopy Devices Market Segmentation

Grand View Research has segmented global robotic endoscopy devices market report based on product, application, end-use, and region:

Robotic Endoscopy Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnostic

• Therapeutic

Robotic Endoscopy Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Laparoscopy

• Bronchoscopy

• Colonoscopy

• Others

Robotic Endoscopy Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Outpatient Facilities

Robotic Endoscopy Devices Regional Outlook (Revenue, USD Million, 2018 - 2030) 

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • South Africa

  • Kuwait

List of Key Players of Robotic Endoscopy Devices Market

• Intuitive Surgical

• Asensus Surgical US, Inc.

• Novus Health Products R&D Consultancy

• Medtronic

• Olympus Corporation

• CMR Surgical Ltd.

• KARL STORZ SE & Co. KG, Tuttlingen

• Virtuoso Surgical, Inc.

• Brainlab AG